News Fulcrum Therapeutics promises new drugs for rare disorders Company launched following $55 million series A funding round.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
